New Drug-Eluting Balloon Matches Standard Stents in Safety and Effectiveness: SELUTION4ISR Trial
A new drug-eluting balloon (DEB) may offer a safer and equally effective alternative to conventional metallic stents for patients with coronary in-stent restenosis (ISR), according to the results of the SELUTION4ISR Trial.
The international study, led by researchers at Mount Sinai Hospital, New York, presented its findings at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference in San Francisco, marking a major advancement in interventional cardiology.
Author summary: New DEB offers safer alternative to metallic stents.
More News
- Sunil Gavaskar Reacts Strongly to South Africa Coach’s “Grovel” Remark After India Series
- India Vs South Africa LIVE Score Updates
- Official Instagram of the Indian Cricket Team Celebrating World Cup Victory
- India vs South Africa Live Score, 1st ODI, RSA: 230/7 (34); Kuldeep Breaks Partnership, Removes Jansen & Breetzke
- India T20I Squad Announcement For South Africa Series Live
- The Board of Control for Cricket in India: Official BCCI Portal
- India Vs South Africa, 1st ODI: Men In Blue Set Unwanted Toss Record - Check Stats
- Instagram Profile of Jolie Pho Jackson – Model, Author, and Actress
- India Vs South Africa Live Score, 1st ODI: Harshit Rana Gets A 3rd! SA 177/5 In Chase Of 350
- Live Cricket Score, Schedule, Latest News, Stats and Videos from India Team